FdaApplication
BLA 125775
Identifiers
- fda_app_no: BLA125775
Properties
| Property | Value |
|---|---|
| applicant_name | GlaxoSmithKline Biologicals |
| application_type | BLA |
| approval_date | 2023-05-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AREXVY | — | 120UG/.5ML | For Injection |
1 product